Mirati Therapeutics (MRTX) PT Raised to $90 at Guggenheim
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Price: $58.70 --0%
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Guggenheim analyst Michael Schmidt raised the price target on Mirati Therapeutics (NASDAQ: MRTX) to $90.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR389 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
